Novaccess Global Stock Price, News & Analysis
Company Description
Novaccess Global (OTC Link: XSNX) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $6.2K.
XSNX stock has declined 75.0% over the past year. Shares last traded at $0.0001.
On a trailing twelve-month basis, Novaccess Global reported revenue of $0 with net income of -$2.7M and diluted earnings per share of $-0.06.
This page provides a comprehensive overview of XSNX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Novaccess Global (XSNX) stock last traded at $0.0001. Over the past 12 months, the stock has lost 75.0%. At a market capitalization of $6.2K, XSNX is classified as a micro-cap stock with approximately 61.7M shares outstanding.
Latest News
Novaccess Global has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, management, partnership, AI. View all XSNX news →
SEC Filings
Novaccess Global has filed 1 recent SEC filing, including 1 Form 10-K. The most recent filing was submitted on January 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all XSNX SEC filings →
Financial Highlights
Novaccess Global generated $0 in revenue over the trailing twelve months, operating income reached -$902K, and net income was -$2.7M. Diluted earnings per share stood at $-0.06. The company generated -$215K in operating cash flow. With a current ratio of 0.01, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Novaccess Global (XSNX) currently stands at 439 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Novaccess Global (XSNX) currently stands at 1.0 days, down 38.3% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 71.3% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 43.9 days.
XSNX Company Profile & Sector Positioning
Novaccess Global (XSNX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing XSNX often look at related companies in the same sector, including BETTER THERAPEUTICS INC (BTTX), Statera Biopharma Inc (STAB), Renovacare (RCAR), Comera Life (CMRA), and Virpax Pharmaceuticals Inc (VRPX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate XSNX's relative position within its industry.